APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dydrogesterone Drug

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

Selected research

Market Outlook & Growth Opportunities

Global Dydrogesterone Drug Market Outlook and Growth Opportunities 2026

Report ID 173987090428 December 2025194 pages

Choose your research edition.

Industry ResearchDydrogesterone Drug Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Dydrogesterone Drug Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Dydrogesterone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dydrogesterone Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dydrogesterone Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

The classification of Dydrogesterone Drug includes Dydrogesterone and Dydrogesterone +Estradiol Compound, and the sale proportion of Dydrogesterone in 2019 is about 75.22%.

Dydrogesterone Drug is widely used for Infertility, Gynecological Diseases, Threatened Abortion, etc. The most proportion of Dydrogesterone Drug is used for Infertility, and the proportion in 2019 is 67.71%.

Read the full market overview

There are mainly two manufacturers in this industry, which is Abbott and Viatris，and their production are in Europe and USA respectively.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 62.27% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 15.77%.

This report provides an overview of the global Dydrogesterone Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dydrogesterone Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dydrogesterone Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dydrogesterone Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Dydrogesterone Drug Segment by Company

Abbott

Viatris

Dydrogesterone Drug Segment by Type

Dydrogesterone

Dydrogesterone+Estradiol Compound

Dydrogesterone Drug Segment by Application

Infertility

Gynecological Diseases

Threatened Abortion

Other

Dydrogesterone Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dydrogesterone Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dydrogesterone Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dydrogesterone Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Dydrogesterone Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dydrogesterone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dydrogesterone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dydrogesterone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dydrogesterone Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dydrogesterone Drug industry.

Chapter 3: Detailed analysis of Dydrogesterone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dydrogesterone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dydrogesterone Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dydrogesterone Drug Industry Trends Table 2. Dydrogesterone Drug Industry Drivers Table 3. Dydrogesterone Drug Industry Opportunities and Challenges Table 4. Dydrogesterone Drug Industry Restraints Table 5. Global Dydrogesterone Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dydrogesterone Drug Revenue Share by Company (2021-2026) Table 7. Global Dydrogesterone Drug Sales Volume by Company (Units) & (2021-2026) Table 8. Global Dydrogesterone Drug Sales Volume Share by Company (2021-2026) Table 9. Global Dydrogesterone Drug Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Dydrogesterone Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dydrogesterone Drug Key Company Manufacturing Base & Headquarters Table 12. Global Dydrogesterone Drug Company, Product Type & Application Table 13. Global Dydrogesterone Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dydrogesterone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Dydrogesterone Table 18. Significant Companies of Dydrogesterone+Estradiol Compound Table 19. Global Dydrogesterone Drug Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Dydrogesterone Drug Sales Volume by Type (2021-2026) & (Units) Table 21. Global Dydrogesterone Drug Sales Volume by Type (2027-2032) & (Units) Table 22. Global Dydrogesterone Drug Sales Volume Share by Type (2021-2026) Table 23. Global Dydrogesterone Drug Sales Volume Share by Type (2027-2032) Table 24. Global Dydrogesterone Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dydrogesterone Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dydrogesterone Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dydrogesterone Drug Sales Value Share by Type (2021-2026) Table 28. Global Dydrogesterone Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Infertility Table 30. Significant Companies of Gynecological Diseases Table 31. Significant Companies of Threatened Abortion Table 32. Significant Companies of Other Table 33. Global Dydrogesterone Drug Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Dydrogesterone Drug Sales Volume by Application (2021-2026) & (Units) Table 35. Global Dydrogesterone Drug Sales Volume by Application (2027-2032) & (Units) Table 36. Global Dydrogesterone Drug Sales Volume Share by Application (2021-2026) Table 37. Global Dydrogesterone Drug Sales Volume Share by Application (2027-2032) Table 38. Global Dydrogesterone Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Dydrogesterone Drug Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Dydrogesterone Drug Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Dydrogesterone Drug Sales Value Share by Application (2021-2026) Table 42. Global Dydrogesterone Drug Sales Value Share by Application (2027-2032) Table 43. Global Dydrogesterone Drug Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Dydrogesterone Drug Sales by Region (2021-2026) & (Units) Table 45. Global Dydrogesterone Drug Sales Market Share by Region (2021-2026) Table 46. Global Dydrogesterone Drug Sales by Region (2027-2032) & (Units) Table 47. Global Dydrogesterone Drug Sales Market Share by Region (2027-2032) Table 48. Global Dydrogesterone Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Dydrogesterone Drug Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Dydrogesterone Drug Sales Value Share by Region (2021-2026) Table 51. Global Dydrogesterone Drug Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Dydrogesterone Drug Sales Value Share by Region (2027-2032) Table 53. Global Dydrogesterone Drug Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Dydrogesterone Drug Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Dydrogesterone Drug Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Dydrogesterone Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Dydrogesterone Drug Sales by Country (2021-2026) & (Units) Table 58. Global Dydrogesterone Drug Sales Market Share by Country (2021-2026) Table 59. Global Dydrogesterone Drug Sales by Country (2027-2032) & (Units) Table 60. Global Dydrogesterone Drug Sales Market Share by Country (2027-2032) Table 61. Global Dydrogesterone Drug Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Dydrogesterone Drug Sales Value Market Share by Country (2021-2026) Table 63. Global Dydrogesterone Drug Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Dydrogesterone Drug Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Dydrogesterone Drug Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Abbott Dydrogesterone Drug Product Portfolio Table 69. Abbott Recent Development Table 70. Viatris Company Information Table 71. Viatris Business Overview Table 72. Viatris Dydrogesterone Drug Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Viatris Dydrogesterone Drug Product Portfolio Table 74. Viatris Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Dydrogesterone Drug Distributors List Table 78. Dydrogesterone Drug Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Dydrogesterone Drug Product Image Figure 2. Global Dydrogesterone Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dydrogesterone Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dydrogesterone Drug Sales (2021-2032) & (Units) Figure 5. Global Dydrogesterone Drug Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Dydrogesterone Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Dydrogesterone Image Figure 10. Dydrogesterone+Estradiol Compound Image Figure 11. Global Dydrogesterone Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Dydrogesterone Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dydrogesterone Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Dydrogesterone Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dydrogesterone Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dydrogesterone Drug Sales Value Share by Type (2021-2032) Figure 17. Infertility Image Figure 18. Gynecological Diseases Image Figure 19. Threatened Abortion Image Figure 20. Other Image Figure 21. Global Dydrogesterone Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Dydrogesterone Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Dydrogesterone Drug Sales Volume Share by Application (2021-2032) Figure 24. Global Dydrogesterone Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Dydrogesterone Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Dydrogesterone Drug Sales Value Share by Application (2021-2032) Figure 27. Global Dydrogesterone Drug Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Dydrogesterone Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Dydrogesterone Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Dydrogesterone Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Dydrogesterone Drug Sales Value (2021-2032) & (US$ Million) Figure 32. North America Dydrogesterone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Dydrogesterone Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Dydrogesterone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Dydrogesterone Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Dydrogesterone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Dydrogesterone Drug Sales Value (2021-2032) & (US$ Million) Figure 38. South America Dydrogesterone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Dydrogesterone Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Dydrogesterone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Dydrogesterone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Dydrogesterone Drug Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Dydrogesterone Drug Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Dydrogesterone
  • Dydrogesterone+Estradiol Compound
Applications
  • Infertility
  • Gynecological Diseases
  • Threatened Abortion
  • Other
Companies covered
  • Abbott
  • Viatris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dydrogesterone Drug Sales Value (2021-2032)
  4. 1.2.2 Global Dydrogesterone Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Dydrogesterone Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dydrogesterone Drug Market Dynamics
  1. 2.1 Dydrogesterone Drug Industry Trends
  2. 2.2 Dydrogesterone Drug Industry Drivers
  3. 2.3 Dydrogesterone Drug Industry Opportunities and Challenges
  4. 2.4 Dydrogesterone Drug Industry Restraints
3 Dydrogesterone Drug Market by Company
  1. 3.1 Global Dydrogesterone Drug Company Revenue Ranking in 2025
  2. 3.2 Global Dydrogesterone Drug Revenue by Company (2021-2026)
  3. 3.3 Global Dydrogesterone Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Dydrogesterone Drug Average Price by Company (2021-2026)
  5. 3.5 Global Dydrogesterone Drug Company Ranking (2024-2026)
  6. 3.6 Global Dydrogesterone Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Dydrogesterone Drug Company Product Type and Application
  8. 3.8 Global Dydrogesterone Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dydrogesterone Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dydrogesterone Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dydrogesterone Drug Market by Type
  1. 4.1 Dydrogesterone Drug Type Introduction
  2. 4.1.1 Dydrogesterone
  3. 4.1.2 Dydrogesterone+Estradiol Compound
  4. 4.2 Global Dydrogesterone Drug Sales Volume by Type
  5. 4.2.1 Global Dydrogesterone Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dydrogesterone Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dydrogesterone Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dydrogesterone Drug Sales Value by Type
  9. 4.3.1 Global Dydrogesterone Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dydrogesterone Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dydrogesterone Drug Sales Value Share by Type (2021-2032)
5 Dydrogesterone Drug Market by Application
  1. 5.1 Dydrogesterone Drug Application Introduction
  2. 5.1.1 Infertility
  3. 5.1.2 Gynecological Diseases
  4. 5.1.3 Threatened Abortion
  5. 5.1.4 Other
  6. 5.2 Global Dydrogesterone Drug Sales Volume by Application
  7. 5.2.1 Global Dydrogesterone Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Dydrogesterone Drug Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Dydrogesterone Drug Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Dydrogesterone Drug Sales Value by Application
  11. 5.3.1 Global Dydrogesterone Drug Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Dydrogesterone Drug Sales Value by Application (2021-2032)
  13. 5.3.3 Global Dydrogesterone Drug Sales Value Share by Application (2021-2032)
6 Dydrogesterone Drug Regional Sales and Value Analysis
  1. 6.1 Global Dydrogesterone Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dydrogesterone Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Dydrogesterone Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Dydrogesterone Drug Sales by Region (2027-2032)
  5. 6.3 Global Dydrogesterone Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dydrogesterone Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dydrogesterone Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dydrogesterone Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Dydrogesterone Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dydrogesterone Drug Sales Value (2021-2032)
  12. 6.6.2 North America Dydrogesterone Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dydrogesterone Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Dydrogesterone Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dydrogesterone Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dydrogesterone Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dydrogesterone Drug Sales Value (2021-2032)
  21. 6.9.2 South America Dydrogesterone Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dydrogesterone Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dydrogesterone Drug Sales Value Share by Country, 2025 VS 2032
7 Dydrogesterone Drug Country-level Sales and Value Analysis
  1. 7.1 Global Dydrogesterone Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dydrogesterone Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dydrogesterone Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Dydrogesterone Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Dydrogesterone Drug Sales by Country (2027-2032)
  6. 7.4 Global Dydrogesterone Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dydrogesterone Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dydrogesterone Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dydrogesterone Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dydrogesterone Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dydrogesterone Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Dydrogesterone Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Dydrogesterone Drug Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Viatris
  8. 8.2.1 Viatris Company Information
  9. 8.2.2 Viatris Business Overview
  10. 8.2.3 Viatris Dydrogesterone Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Viatris Dydrogesterone Drug Product Portfolio
  12. 8.2.5 Viatris Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dydrogesterone Drug Value Chain Analysis
  2. 9.1.1 Dydrogesterone Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dydrogesterone Drug Sales Mode & Process
  6. 9.2 Dydrogesterone Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dydrogesterone Drug Distributors
  9. 9.2.3 Dydrogesterone Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst